HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

A-E-Mulsin® N; -forte; -fortissimum overview
Erhöhter Bedarf bzw. Mangel an Vit. A und E, besonders auch bei Resorptionsstörungen; zur Steigerung der Infektionsabwehr.
banner_pass = 1

EPG Knowledge Centres
Working with our pharmaceutical industry partners we have compiled the EPG educational library. The library contains interactive educational resources from specific drug treatments through to more general disease and management guides.

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: Deutsch
 
 
Related DrugsDrug Details
A-E-Mulsin® N; -forte; -fortissimum
Drug Class Description :

Kombinationen

Generic Name :

A-E-Mulsin® N Emulsion

Drug description :

1 g enth.: Retinolpalmitat (Vit. A) 5500 I.E. 'alpha'-Tocopherolacetat (Vit. E) 75 mg 1 Tr. = 275 I.E. Vit. A und 3,8 I.E. Vit. E. Vit. E.

Presentation :

A-E-Mulsin® N; -forte; -fortissimum

Indications :

Erhöhter Bedarf bzw. Mangel an Vit. A und E, besonders auch bei Resorptionsstörungen; zur Steigerung der Infektionsabwehr.

Adult Dosage :

Citronensäure 1H2O, Sesamöl, Sorbitol-Lsg. 70%, gereinigtes Wasser, Arabisches Gummi, Natriumbenzoat, Kaliumsorbat, Palmitoylascorbinsäure (E 304), 'alpha'-Tocopherol (E 307), Lecithin (E 322), Citronensäure (E 330), Mono- und Diglyceride von Speisefettsäuren (E 471). Palmitoylascorbinsäure (E 304), 'alpha'-Tocopherol (E 307), Lecithin (E 322), Citronensäure (E 330), Mono- und Diglyceride von Speisefettsäuren (E 471).

Child Dosage :

A-E-Mulsin® forte Emulsion
Zus.: 1 ml enth.: Retinolpalmitat (Vit. A) 30 000 I.E. 'alpha'-Tocopherolacetat (Vit. E) 75 mg 1 Tr. = 1360 I.E. Vit. A und 3,4 I.E. Vit. E.
Weit. Bestandteile: Citronensäure 1H2O, Sesamöl, Sorbitol-Lsg. 70%, gereinigtes Wasser, Arabisches Gummi, Natriumbenzoat, Kaliumsorbat,

A-E-Mulsin® fortissimum Emulsion
Zus.: 1 g enth.: Retinolpalmitat (Vit. A) 30 000 I.E. RRR-'alpha'-Tocopherolacetat (natürl. Vit. E) 220,58 mg 1 Tr. = 1500 I.E. Vit. A und 15 I.E.
Weit. Bestandteile: 'alpha'-Tocopherol, Citronensäure 1H2O, Sorbitol-Lsg. 70%, gereinigtes Wasser, Arabisches Gummi, Natriumbenzoat, Kaliumsorbat.

Special Precautions :

Hypervitaminose A.

Adverse Reactions :

V 14

Manufacturer :

Mucos

Drug Updated :

03 June 2010

Related Drugs - Chemisch definierte Vitamine
Soft Tissue Sarcoma Niemann-Pick Type C Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Ophthalmics - understanding, management, diagnosis and treatment information
New and updated Drugs
German Drugs EPG Medical News Feed
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES